Author

Miri Yavzori 1

1 Sheba Medical Center, Tel-Hashomer, Israel

CAN EARLY DRUG AND ANTI-INFLIXIMAB-ANTIBODY LEVELS PREDICT PRIMARY NON RESPONSE TO INFLIXIMAB THERAPY?

Haggai Bar-Yoseph, Yehuda Chowers, Nina Levhar, Limor Selinger, Uri Manor, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Abraham (Rami) Eliakim, Shomron Ben-Horin, Bella Ungar

CROSS-IMMUNOGENICITY: ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED IBD PATIENTS SIMILARLY RECOGNIZE THE BIO-SIMILAR REMSIMA

Shomron Ben-Horin, Miri Yavzori, Orit Picard, SooYoung Lee, SungHwan Kim, Yehuda Chowers

EARLY VEDOLIZUMAB DRUG LEVELS AND INDUCTION SUCCESS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Bella Ungar, Uri Kopylov, Mattitiahu Waterman, Ola Haj-Natour, Miri Yavzori, Orit Picard, Ella Fudim, Yehuda Chowers, Abraham (Rami) Eliakim, Shomron Ben-Horin

Infliximab levels & antibodies in IBD- related peripheral arthralgia

Asaf Levartovsky, Bella Ungar, Miri Yavzori, Orit Picard, Ella Fudim, Abraham (Rami) Eliakim, Stéphane Paul, Xavier Roblin, Shomron Ben-Horin, Uri Kopylov

PROLONGED RECURRENT ABDOMINAL PAIN IS ASSOCIATED WITH ON-GOING UNDERLYING MUCOSAL INFLAMMATION IN PATIENTS WHO HAD AN EPISODE OF ACUTE COMPLICATED DIVERTICULITS

Adi Lahat, Daniela Necula, Miri Yavzori, Orit Picard, Abraham (Rami) Eliakim, Shomron Ben-Horin

THE TEMPORAL EVOLUTION OF ANTI-DRUG ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH INFLIXIMAB

Yehuda Chowers, Miri Yavzori, Orit Picard, Ofir Har-Noy, Uri Kopylov, Abraham (Rami) Eliakim, Shomron Ben-Horin

THE TEMPORAL EVOLUTION OF IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ADALIMUMAB

Bella Ungar, Tal Engel, Doron Yablecovich, Adi Lahat, Alon Lang, Benjamin Avidan, Ofir Har-Noy, Nina Levhar, Limor Selinger, Sandra Neuman, Ola Haj Natour, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Yehuda Chowers, Timna Naftali, Efrat Broide, Eyal Shachar, Abraham (Rami) Eliakim, Shomron Ben-Horin

Item 1 - 7 / 10
1